Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy

Publisher： Karger

E-ISSN： 1660-2110|104|1|c20-c27

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.104, Iss.1, 2006-05, pp. : c20-c27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin Converting Enzyme Inhibitors and Risk of Mood Disorders

By  

Psychotherapy and Psychosomatics, Vol. 85, Iss. 4, 2016-05 ,pp. : 250-252

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors and Smoking Cessation

By  

Respiration, Vol. 74, Iss. 4, 2007-05 ,pp. : 478-478

Karger

Access to resources Recommend Favorite

Reducing the Risk of Recurrences after Pulmonary Vein Isolation: What Is the Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers?

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 11-13

Karger

Access to resources Recommend Favorite

Angiotensin‐converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 593-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin‐converting enzyme inhibitor‐induced angioedema and icatibant: a new hope

By  

INTERNAL MEDICINE JOURNAL, Vol. 1444-0903, Iss. 10, 2015-10 ,pp. : 1093-1094

John Wiley & Sons Inc

Access to resources Recommend Favorite